Gera Tarun, Sachdev H P S, Nestel Penelope, Sachdev Sudeep Singh
S.L. Jain Hospital, New Delhi, India.
J Pediatr Gastroenterol Nutr. 2007 Apr;44(4):468-86. doi: 10.1097/01.mpg.0000243440.85452.38.
To evaluate the effect of iron supplementation on haemoglobin (Hb) in children through a systematic review of randomised controlled trials.
Electronic databases, personal files, hand search of reviews, bibliographies of books, and abstracts and proceedings of international conferences were reviewed. Randomised controlled trials evaluating change in Hb levels with interventions that included oral or parenteral iron supplementation or iron-fortified formula milk or cereals were analysed.
A total of 55 trials (56 cohorts) provided relevant information. Publication bias was evident (P < 0.001). The pooled estimate (random-effects model) for change in Hb with iron supplementation (weighted mean difference) was 0.74 g/dL (95% CI, 0.61-0.87; P < 0.001; P < 0.001 for heterogeneity). Lower baseline Hb level, oral medicinal iron supplementation, and malarial nonhyperendemic region were significant predictors of greater Hb response and heterogeneity. Projections suggested that, on average, between 37.9% and 62.3% of baseline anaemia (Hb <11 g/dL) was responsive to iron supplementation among children under 6 years of age; the corresponding range for malarial hyperendemic regions was 5.8% to 31.8%.
This systematic review indicates that iron supplementation increases Hb levels in children significantly but modestly. The increase is greater in subjects who are anaemic at the start of the trial and lower in malarial hyperendemic areas and in those consuming iron-fortified food. The projected reductions in prevalence of anaemia with iron supplementation alone highlight the need for additional area-specific interventions, particularly in malaria-prone regions.
通过对随机对照试验的系统评价,评估铁补充剂对儿童血红蛋白(Hb)的影响。
检索了电子数据库、个人档案、综述的手工检索、书籍书目以及国际会议的摘要和论文集。分析了评估口服或肠外铁补充剂、铁强化配方奶或谷物等干预措施对Hb水平变化的随机对照试验。
共有55项试验(56个队列)提供了相关信息。存在明显的发表偏倚(P < 0.001)。铁补充剂使Hb变化的合并估计值(随机效应模型)(加权平均差)为0.74 g/dL(95%可信区间,0.61 - 0.87;P < 0.001;异质性P < 0.001)。较低的基线Hb水平、口服药用铁补充剂以及非疟疾高流行地区是Hb反应更大和异质性的显著预测因素。预测表明,平均而言,6岁以下儿童中,37.9%至62.3%的基线贫血(Hb < 11 g/dL)对铁补充剂有反应;疟疾高流行地区的相应范围为5.8%至31.8%。
本系统评价表明,铁补充剂能显著但适度地提高儿童的Hb水平。在试验开始时贫血的受试者中升高幅度更大,在疟疾高流行地区以及食用铁强化食品的人群中升高幅度较小。仅通过铁补充剂预计的贫血患病率降低凸显了针对特定地区采取额外干预措施的必要性,特别是在疟疾高发地区。